MedCity News January 16, 2025
Katie Adams

Teal Health raised $10 million in seed funding, taking its total funding to $23 million. The company has submitted an application to the FDA for its at-home cervical cancer screening kit, which seeks to give patients an alternative to the in-office pap smear.

Roughly 80% of women will get human papillomavirus (HPV) in their lifetime. For many, especially those who have gotten an HPV vaccine, the virus will go away on its own within two years. But for others, the infection could lead to cervical cancer. In fact, more than 90% of cervical cancer cases are caused by an HPV infection.

Despite these figures, many women don’t get tested for HPV. CDC guidelines say that women should be tested regularly...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Home, Patient / Consumer, Provider
Why Saint Luke's plans to expand hospital at home
AdventHealth Rolls Out New Hospital-At-Home Program
'Definitions matter': Cleveland Clinic's approach to hospital at home
Connecting for Health at Home: A Unified Field Theory from #CES2025 (On Samsung, Withings, and Panasonic)
How Private-Duty Nursing Empowers Children with Complex Needs At Home

Share This Article